skip to main content
Idioma:
Refinado por: materia: Male eliminar materia: Oncology eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
Material Type:
Artículo 		Añadir a Mi Portal

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

CERESOLI, G. L ; ZUCALI, P. A ; SOTO-PARRA, H ; DE VINCENZO, F ; BRUZZONE, A ; LORENZI, E ; GIANONCELLI, L ; ERCOLI, B ; GIORDANO, L ; SANTORO, A ; MENCOBONI, M ; BOTTA, M ; GROSSI, F ; CORTINOVIS, D ; ZILEMBO, N ; RIPA, C ; TISEO, M ; FAVARETTO, A. G

British journal of cancer, 2013-08, Vol.109 (3), p.552-558 [Revista revisada por pares]

Basingstoke: Nature Publishing Group

Texto completo disponible

Citas Citado por
2
Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
Material Type:
Artículo 		Añadir a Mi Portal

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

Gridelli, Cesare ; Perrone, Francesco ; Gallo, Ciro ; Cigolari, Silvio ; Rossi, Antonio ; Piantedosi, Francovito ; Barbera, Santi ; Ferraù, Francesco ; Piazza, Elena ; Rosetti, Francesco ; Clerici, Maurizia ; Bertetto, Oscar ; Robbiati, Sergio Federico ; Frontini, Luciano ; Sacco, Cosimo ; Castiglione, Federico ; Favaretto, Adolfo ; Novello, Silvia ; Migliorino, Maria Rita ; Gasparini, Giampietro ; Galetta, Domenico ; Iaffaioli, Rosario Vincenzo ; Gebbia, Vittorio

JNCI : Journal of the National Cancer Institute, 2003-03, Vol.95 (5), p.362-372 [Revista revisada por pares]

United States: Oxford University Press

Texto completo disponible

Citas Citado por
3
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients
Material Type:
Artículo 		Añadir a Mi Portal

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients

Pasello, Giulia ; Fabricio, Aline S C ; Del Bianco, Paola ; Salizzato, Valentina ; Favaretto, Adolfo ; Piccin, Luisa ; Zustovich, Fable ; Fabozzi, Alessio ; De Rossi, Costanza ; Pigozzo, Jacopo ; De Nuzzo, Mattia ; Cappelletto, Elia ; Bonanno, Laura ; Palleschi, Dario ; De Salvo, Gian Luca ; Guarneri, Valentina ; Gion, Massimo ; Chiarion-Sileni, Vanna

Journal of translational medicine, 2024-03, Vol.22 (1), p.242-16, Article 242 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
4
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
Material Type:
Artículo 		Añadir a Mi Portal

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

Gridelli, C. ; Morgillo, F. ; Favaretto, A. ; de Marinis, F. ; Chella, A. ; Cerea, G. ; Mattioli, R. ; Tortora, G. ; Rossi, A. ; Fasano, M. ; Pasello, G. ; Ricciardi, S. ; Maione, P. ; Di Maio, M. ; Ciardiello, F.

Annals of oncology, 2011-07, Vol.22 (7), p.1528-1534 [Revista revisada por pares]

Oxford: Elsevier Ltd

Texto completo disponible

Citas Citado por
5
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study
Material Type:
Artículo 		Añadir a Mi Portal

Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study

Favaretto, Ricardo L. ; Bahadori, Atessa ; Mathieu, Romain ; Haitel, Andrea ; Grubmüller, Bernhard ; Margulis, Vitaly ; Karam, Jose A. ; Rouprêt, Morgan ; Seitz, Christian ; Karakiewicz, Pierre I. ; Cunha, Isabela W. ; Zequi, Stenio C. ; Wood, Christopher G. ; Weizer, Alon Z. ; Raman, Jay D. ; Remzi, Mesut ; Rioux-Leclercq, Nathalie ; Jacquet-Kammerer, Solene ; Bensalah, Karim ; Lotan, Yair ; Bachmann, Alexander ; Rink, Michael ; Briganti, Alberto ; Shariat, Shahrokh F.

World journal of urology, 2017-01, Vol.35 (1), p.113-120 [Revista revisada por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponible

Citas Citado por
6
Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non–Small-Cell Lung Cancer
Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non–Small-Cell Lung Cancer
Material Type:
Artículo 		Añadir a Mi Portal

Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non–Small-Cell Lung Cancer

Scagliotti, Giorgio V. ; Fossati, Roldano ; Torri, Valter ; Crinò, Lucio ; Giaccone, Giuseppe ; Silvano, Giovanni ; Martelli, Massimo ; Clerici, Maurizia ; Cognetti, Francesco ; Tonato, Maurizio

JNCI : Journal of the National Cancer Institute, 2003-10, Vol.95 (19), p.1453-1461 [Revista revisada por pares]

Cary, NC: Oxford University Press

Texto completo disponible

Citas Citado por
7
Are PubMed alone and English literature only enough for a meta-analysis?
Are PubMed alone and English literature only enough for a meta-analysis?
Material Type:
Artículo 		Añadir a Mi Portal

Are PubMed alone and English literature only enough for a meta-analysis?

Zheng, B. ; Zheng, W. ; Zhu, Y. ; Guo, C. ; Wu, W. ; Chen, C.

Annals of oncology, 2013-04, Vol.24 (4), p.1130-1130 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
8
The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma
The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma
Material Type:
Artículo 		Añadir a Mi Portal

The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma

Cássio Zequi, Stênio de ; Fregnani, José Humberto G. T. ; Favaretto, Ricardo L. ; Costa, Walter H. ; Madeira Campos, Rodrigo S. ; Fonseca, Francisco P. ; Guimaraes, Gustavo C. ; Soares, Fernando A. ; da Cunha, Isabela W. ; Lopes, Ademar

World journal of urology, 2013-10, Vol.31 (5), p.1197-1203 [Revista revisada por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponible

Citas Citado por
9
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial
Material Type:
Artículo 		Añadir a Mi Portal

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

Paccagnella, Adriano ; Favaretto, A. ; Oniga, F. ; Barbieri, F. ; Ceresoli, G. ; Torri, W. ; Villa, E. ; Verusio, C. ; Cetto, G.L. ; Santo, A. ; De Pangher, V. ; Artioli, F. ; Cacciani, G.C. ; Parodi, G. ; Soresi, F. ; Ghi, M.G. ; Morabito, A. ; Biason, R. ; Giusto, M. ; Mosconi, P. ; Chiarion Sileni, V.

Lung cancer (Amsterdam, Netherlands), 2004, Vol.43 (1), p.83-91 [Revista revisada por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponible

Citas Citado por
10
Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients
Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients
Material Type:
Artículo 		Añadir a Mi Portal

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

Chiarion Sileni, V ; Nortilli, R ; Aversa, S M ; Paccagnella, A ; Medici, M ; Corti, L ; Favaretto, A G ; Cetto, G L ; Monfardini, S

Melanoma research, 2001-04, Vol.11 (2), p.189-196 [Revista revisada por pares]

England

Texto completo disponible

Citas Citado por

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de1993  (2)
  2. 1993Hasta1997  (4)
  3. 1998Hasta2002  (2)
  4. 2003Hasta2011  (5)
  5. Después de 2011  (5)
  6. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora